Level of Healthcare Facility and Psychosocial Factors Influence Perceived Self-Efficacy for Appropriate Use of Hydroxyurea: Experience from Caregivers of Children with Sickle Cell Disease in Tanzania
<b>Background</b>: Sickle cell disease (SCD) is associated with high physical and psychosocial burden among patients and their families. Hydroxyurea (HU) improves health-related quality of life by preventing SCD complications. Despite its availability, HU is underutilised in Tanzania. Perceived self-efficacy for appropriate medication use influences medication usage among individuals with chronic illnesses. We studied factors associated with caregivers' perceived self-efficacy for appropriate use of HU and its association with HU usage among children with SCD in Dar-es-Salaam. <b>Methods</b>: We conducted a cross-sectional study from May to August 2023. We enrolled 374 caregivers of children with SCD from two regional and two national hospitals. We adapted the self-efficacy for appropriate medication use scale, a multidimensional perceived social support scale, and a patient health questionnaire for assessment of self-efficacy, social support, and depressive symptoms, respectively. <b>Results</b>: Three-quarters of caregivers had high perceived self-efficacy scores for medication use. Attending national hospitals, high social support, and absence of depressive symptoms were positively associated with perceived self-efficacy (adjusted beta coefficient aβ 2.3, 95% CI 0.5-4.2; aβ 9, 95% CI 7.1-10.9; and aβ 5.3, 95% CI 2.8-7.8, respectively). Caregivers with high self-efficacy were 5.3 times more likely to give HU to their children compared with those with low self-efficacy (incidence rate ratio 5.3, 95% CI 3.3-8.3). <b>Conclusions</b>: Hospital levels and psychosocial factors influence caregivers' perceived self-efficacy for appropriate HU use. We recommend targeted interventions to enhance psychosocial support among caregivers to increase caregivers' perceived self-efficacy and HU utilization among children with SCD in Tanzania.
Authors
- Emmanuel Balandya (ORCID: https://orcid.org/0000-0002-3707-9985)
- Elia J. Mmbaga (ORCID: https://orcid.org/0000-0003-3768-0225)
- Calvin Swai (ORCID: https://orcid.org/0000-0002-3318-4702)
- Tone Kristin Omsland (ORCID: https://orcid.org/0000-0002-0808-3133)
- Emmy Metta (ORCID: https://orcid.org/0000-0002-4980-6094)
- Agnes Jonathan (ORCID: https://orcid.org/0000-0001-9928-0732)
- Julie Makani (ORCID: https://orcid.org/0000-0002-4801-6250)
- Mwashungi Ally (ORCID: https://orcid.org/0009-0008-4953-8959)
- Kåre Moen (ORCID: https://orcid.org/0000-0002-4537-9654)
- Melkizedeck Leshabari (ORCID: https://orcid.org/0000-0003-4789-4251)
- Mbonea Yonazi (ORCID: https://orcid.org/0000-0002-0764-0196)
- Deodatus Kakoko (ORCID: https://orcid.org/0009-0007-2394-3713)
Institutions
- Muhimbili University of Health and Allied Sciences (TZ)
- University of Oslo (NO)
- The University of Dodoma (TZ)
- Muhimbili National Hospital (TZ)
Publication Details
- Journal
- Healthcare
- Published
- 2025-06-24
- DOI
- https://doi.org/10.3390/healthcare13131500
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00